Cervicobrachial Neuralgia Clinical Trial
Official title:
Hypoalgesic Effect of Median Nerve Neural Mobilization Versus Ibuprofen Pharmacologic Treatment in Patients With Cervicobrachial Pain
The purpose of this study is to compare the effectivity of Median Nerve Neural Mobilization and oral Ibuprofen in treating patients who suffer cervicobrachial pain
Median Nerve Neural Mobilization and Ibuprofen both relieve cervicobrachial pain, but this
happens through different mechanisms and with a different onset of side effects. Median
Nerve Neural Mobilization is a physical therapy technique that achieves pain relief through
mechanical stimulation of the median nerve and the brachial plexus. The proper mechanical
stimulation of the nerve and its surrounding neural tissue induces a wide variety of
physiologic responses that may reduce cervicobrachial pain including the activation of
descending nervous system pain modulation mechanisms, all though the entire set of
underlying reasons for this pain reduction is not completely understood. Among the effects
caused by the Neural Tissue Mobilization that produce pain relief are: intraneural edema
reduction, changes on the intraneural nerve pressure,dispersion of pro-inflammatory
substances and an increase in nerve mobility
Ibuprofen is a nonsteroidal anti-inflammatory drug used worldwide to control pain, fever and
inflammation.Oral intake of Ibuprofen produces a hypoalgesic effect due to biochemical
inhibition of the COX enzymes, which convert arachidonic acid to prostaglandin H2 (PGH2).
PGH2, which in turn, is converted by other enzymes to several types of prostaglandins and
thromboxanes (which are mediators of pain and inflammation).
Side effects derived from the oral intake of Ibuprofen are related to its systemic action
and can be severe in some patients. This fact suggests that oral Ibuprofen may not be
suitable to use in all types of patients suffering from cervicobrachial pain, meanwhile the
Median Nerve Neural Mobilization has little to no side effects known. This reveals a point
of interest in determining comparative effectiveness between this two therapeutic options in
the treatment of cervicobrachial pain.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00241215 -
Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome
|
Phase 4 | |
Recruiting |
NCT04475445 -
Fluoroscopic Guided Interlaminar Epidural Versus Ultrasound Guided Transforaminal Epidural in the Treatment of Unilateral Cervicobrachialgia.
|
N/A | |
Completed |
NCT02596815 -
Hypoalgesic Effect of Median Nerve Neural Mobilization Compared to a Controlled Group
|
N/A | |
Completed |
NCT02595294 -
Hypoalgesic Effect of Neural Mobilization
|
N/A | |
Recruiting |
NCT03397459 -
Cervicobrachial Neuralgia and Sagital Balance of the Cervical Spine
|
N/A | |
Completed |
NCT02632357 -
Longitudinal Experimental Study on ULNTT and Cervico-Thoracic Spine Motion Patterns Relationship
|
N/A | |
Completed |
NCT01518582 -
GRANVIA®-C Cervical Disc Prosthesis Multicenter European Pilot Study
|
N/A |